An oxaliplatin(iv) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment.

Chem Commun (Camb)

NTU-Northwestern Institute for Nanomedicine, Interdisciplinary Graduate School, Nanyang Technological University, Singapore.

Published: November 2018

A redox-responsive supramolecular nanocarrier was constructed from the self-assembly of spermine modified cyclodextrin and oxaliplatin prodrug. The nanocarrier could preferentially accumulate in polyamine transporter over-expressing HCT116 cells, releasing drugs under a reducing intracellular environment to maximize anticancer treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c8cc07858kDOI Listing

Publication Analysis

Top Keywords

oxaliplatiniv prodrug-based
4
prodrug-based supramolecular
4
supramolecular self-delivery
4
self-delivery nanocarrier
4
nanocarrier targeted
4
targeted colorectal
4
colorectal cancer
4
cancer treatment
4
treatment redox-responsive
4
redox-responsive supramolecular
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!